RxDoctor Payments Data

James Schultz

Family Medicine · Escondido, CANPI 1356376164

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,787 of the $8,823 with a category attached, or 65.6%. 11 manufacturers reported payments, led by Eli Lilly at 34.5% of the total. Reporting peaked in 2023 at $3,863 and has fallen 72.7% since, to $1,055 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,823in general payments, 2019–2025

Across 55 payments — averaging $160.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$3K
  • Chiesi USA, Inc.$2K
  • Shionogi Inc$2K
  • Medtronic$2K
  • Novo Nordisk$146
  • AstraZeneca$94
  • plus $161 from 5 others
$2,672,108in research payments, 2019–2025

Across 830 payments — averaging $3219.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.6M
  • Hikma Pharmaceuticals USA$481K
  • Novo Nordisk AS$171K
  • Cipla USA Inc.$126K
  • Abbott$88K
  • Indivior Inc.$53K
  • plus $147K from 6 others

What the payments were for

  • Speaking & faculty fees$1,56018%
  • Travel & lodging$5,78766%
  • Food & beverage$1,47517%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,823 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium54$2,142
Gabapentin23$1,166
Tamsulosin Hcl13$786
Lisinopril34$614
Amlodipine Besylate20$350

Paid to pharmacies, not to this prescriber.

Other family medicine in Escondido

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →